Buprenorphine Treatment for Opioid Use Disorder
Buprenorphine prescribed and managed by telehealth for opioid use disorder. No clinic required. Physician-led care in California, Washington, and Nevada.
Buprenorphine is the active molecule behind most modern medication treatment for opioid use disorder. It is prescribed under several brand names (Suboxone is the best known) but the science that makes it effective belongs to the molecule itself. This page is about that molecule: how it behaves in the body, why it carries a wide safety margin, and how the law now allows a physician to prescribe it to you over video. Rezolv Health manages buprenorphine treatment entirely by telehealth in California, Washington, and Nevada.
What buprenorphine is
Buprenorphine is a semi-synthetic compound first developed in the 1960s and later recognized as a uniquely suited treatment for opioid dependence. Unlike heroin, oxycodone, or fentanyl (which are full opioid agonists), buprenorphine is a partial agonist. That single pharmacological distinction is the reason it can relieve withdrawal and cravings while being far harder to overdose on.
It is most often dispensed as a film or tablet that dissolves under the tongue, frequently combined with naloxone. The naloxone is inert when the medication is taken correctly and is included only to discourage attempts to misuse the product by injection. The brand Suboxone is one such buprenorphine-naloxone formulation; mono-product buprenorphine without naloxone also exists and is used in specific situations such as pregnancy.
The pharmacology: partial agonism and the ceiling effect
A full opioid agonist activates the mu-opioid receptor completely, and the more you take, the greater the effect, including the suppression of breathing that causes fatal overdoses. Buprenorphine binds tightly to the same receptor but only partially activates it. Past a moderate dose, additional buprenorphine produces no additional opioid effect. Pharmacologists call this the ceiling effect, and it is what gives the drug its safety margin: the respiratory depression that kills people on full agonists largely plateaus with buprenorphine.
That same tight binding has a second consequence. Buprenorphine holds onto the receptor more strongly than most other opioids, so it occupies and shields the receptor. At an adequate dose this blunts the effect of other opioids taken on top of it, which both reduces the incentive to use and adds a layer of overdose protection. The flip side is that starting buprenorphine too soon after a full opioid can briefly displace that opioid and provoke precipitated withdrawal, which is why timing the first dose matters and why your physician will plan it with you.
For a broader, condition-level view of why medication is the standard of care, see our opiate addiction treatment page.
How it differs from methadone
Methadone is the other long-established medication for opioid use disorder, and comparing the two clarifies what makes buprenorphine distinctive. Methadone is a full agonist with no ceiling effect, so it is highly effective but carries greater overdose risk and, by federal rule, can be dispensed for addiction only through licensed opioid treatment programs, typically requiring daily in-person visits, at least early on.
Buprenorphine's partial agonism and safety profile let it be prescribed by an individual physician and taken at home. That difference is not cosmetic: it is the reason buprenorphine can be delivered by telehealth at all, while methadone for addiction cannot. For people with jobs, children, or distance between them and the nearest clinic, that accessibility is often decisive.
Why telehealth prescribing is legal
For years, a federal law called the Ryan Haight Act generally required an in-person medical exam before a controlled substance could be prescribed online. During the COVID-19 public health emergency, regulators waived that requirement for buprenorphine, and a physician could initiate treatment by audio-video visit. Rather than letting the waiver lapse, the DEA and SAMHSA have repeatedly extended telemedicine flexibilities for buprenorphine (currently through the end of 2026) while a permanent framework is finalized.
The practical upshot is straightforward: a licensed physician can legally evaluate you and prescribe buprenorphine over a secure video visit, with no in-person appointment required to begin. Rezolv Health operates within these rules.
Availability by state
| State | Insurance | Availability |
|---|---|---|
| California | Private pay: see California pricing | Telehealth statewide |
| Washington | Most major commercial plans, Medicare, Medicaid/Apple Health, and TRICARE; Kaiser and HMO plans are not accepted; self-pay available | Telehealth statewide + in-person University Place |
| Nevada | Most major commercial plans, Medicare, Medicaid, and TRICARE; Kaiser and HMO plans are not accepted; self-pay available | Telehealth statewide + in-person Reno |
Frequently asked questions
Is buprenorphine the same thing as Suboxone?
Why is buprenorphine considered safer than other opioids?
Can a doctor really prescribe buprenorphine without seeing me in person?
What is precipitated withdrawal and how is it avoided?
How is buprenorphine taken?
Does buprenorphine show up as an opioid on a drug test?
How long will I stay on buprenorphine?
Ready when you are
Ready to get started?
Complete our short intake quiz and get matched to the right care.